BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25028927)

  • 1. Gene expression profiling in leiomyosarcomas and undifferentiated pleomorphic sarcomas: SRC as a new diagnostic marker.
    Villacis RA; Silveira SM; Barros-Filho MC; Marchi FA; Domingues MA; Scapulatempo-Neto C; Aguiar S; Lopes A; Cunha IW; Rogatto SR
    PLoS One; 2014; 9(7):e102281. PubMed ID: 25028927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.
    Mills AM; Beck AH; Montgomery KD; Zhu SX; Espinosa I; Lee CH; Subramanian S; Fletcher CD; van de Rijn M; West RB
    Am J Surg Pathol; 2011 Apr; 35(4):583-9. PubMed ID: 21412072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic signatures predict poor outcome in undifferentiated pleomorphic sarcomas and leiomyosarcomas.
    Silveira SM; Villacis RA; Marchi FA; Barros Filho Mde C; Drigo SA; Neto CS; Lopes A; da Cunha IW; Rogatto SR
    PLoS One; 2013; 8(6):e67643. PubMed ID: 23825676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating soft tissue leiomyosarcoma and undifferentiated pleomorphic sarcoma: A miRNA analysis.
    Guled M; Pazzaglia L; Borze I; Mosakhani N; Novello C; Benassi MS; Knuutila S
    Genes Chromosomes Cancer; 2014 Aug; 53(8):693-702. PubMed ID: 24771630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
    Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
    Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin?
    Carneiro A; Francis P; Bendahl PO; Fernebro J; Akerman M; Fletcher C; Rydholm A; Borg A; Nilbert M
    Lab Invest; 2009 Jun; 89(6):668-75. PubMed ID: 19290004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong smooth muscle differentiation is dependent on myocardin gene amplification in most human retroperitoneal leiomyosarcomas.
    Pérot G; Derré J; Coindre JM; Tirode F; Lucchesi C; Mariani O; Gibault L; Guillou L; Terrier P; Aurias A
    Cancer Res; 2009 Mar; 69(6):2269-78. PubMed ID: 19276386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleomorphic Undifferentiated Uterine Sarcoma in a Young Patient Presenting With Elevated Beta-hCG and Rare Variants of Benign Leiomyoma: A Case Report and Review of the Literature.
    Krishnan V; Sauthier P; Provencher D; Rahimi K
    Int J Gynecol Pathol; 2020 Jul; 39(4):362-366. PubMed ID: 31033798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma.
    Ragazzini P; Gamberi G; Pazzaglia L; Serra M; Magagnoli G; Ponticelli F; Ferrari C; Ghinelli C; Alberghini M; Bertoni F; Picci P; Benassi MS
    Histol Histopathol; 2004 Apr; 19(2):401-11. PubMed ID: 15024701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
    Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
    Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pleomorphic and dedifferentiated leiomyosarcoma: a clinicopathologic analysis].
    Sun M; Liu JG; Weng QY; Yu L; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):87-93. PubMed ID: 29429158
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison between retroperitoneal leiomyosarcoma and dedifferentiated liposarcoma.
    Ishii T; Kohashi K; Ootsuka H; Iura K; Maekawa A; Yamada Y; Bekki H; Yoshimoto M; Yamamoto H; Iwamoto Y; Oda Y
    Pathol Res Pract; 2017 Jun; 213(6):634-638. PubMed ID: 28552535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel diagnostic gene expression signature to discriminate uterine leiomyoma from leiomyosarcoma.
    Adams CL; Dimitrova I; Post MD; Gibson L; Spillman MA; Behbakht K; Bradford AP
    Exp Mol Pathol; 2019 Oct; 110():104284. PubMed ID: 31301306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gene expression signature associated with metastatic outcome in human leiomyosarcomas.
    Lee YF; John M; Falconer A; Edwards S; Clark J; Flohr P; Roe T; Wang R; Shipley J; Grimer RJ; Mangham DC; Thomas JM; Fisher C; Judson I; Cooper CS
    Cancer Res; 2004 Oct; 64(20):7201-4. PubMed ID: 15492233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-grade sarcoma diagnosis and prognosis: Biomarker discovery by mass spectrometry imaging.
    Lou S; Balluff B; de Graaff MA; Cleven AH; Briaire-de Bruijn I; Bovée JV; McDonnell LA
    Proteomics; 2016 Jun; 16(11-12):1802-13. PubMed ID: 27174013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma.
    Liu W; Tong H; Zhang C; Zhuang R; Guo H; Lv C; Yang H; Lin Q; Guo X; Wang Z; Wang Y; Shen F; Wang S; Dai C; Wang G; Liu J; Lu W; Zhang Y; Zhou Y
    BMC Cancer; 2020 Oct; 20(1):1035. PubMed ID: 33115433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile.
    Hofvander J; Puls F; Pillay N; Steele CD; Flanagan AM; Magnusson L; Nilsson J; Mertens F
    J Pathol; 2019 Dec; 249(4):425-434. PubMed ID: 31313299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas.
    Davis JL; Horvai AE
    Histopathology; 2016 Jul; 69(1):84-90. PubMed ID: 26644288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype.
    Chang HY; Dermawan J; Sharma A; Dickson B; Turashvili G; Torrence D; Nucci M; Chiang S; Oliva E; Kirchner M; Stenzinger A; Mechtersheimer G; Antonescu C
    Mod Pathol; 2024 Feb; 37(2):100402. PubMed ID: 38141829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.